Alfresa Holdings Corporation (ALFRY)
OTCMKTS · Delayed Price · Currency is USD
16.36
0.00 (0.00%)
At close: Feb 10, 2026
Alfresa Holdings Revenue
Alfresa Holdings had revenue of 833.32B JPY in the quarter ending December 31, 2025, with 3.39% growth. This brings the company's revenue in the last twelve months to 3.06T, up 4.11% year-over-year. In the fiscal year ending March 31, 2025, Alfresa Holdings had annual revenue of 2.96T with 3.59% growth.
Revenue (ttm)
3.06T JPY
Revenue Growth
+4.11%
P/S Ratio
0.15
Revenue / Employee
245.89M JPY
Employees
12,452
Market Cap
3.03B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 2.96T | 102.55B | 3.59% |
| Mar 31, 2024 | 2.86T | 162.43B | 6.02% |
| Mar 31, 2023 | 2.70T | 110.43B | 4.27% |
| Mar 31, 2022 | 2.59T | -17.53B | -0.67% |
| Mar 31, 2021 | 2.60T | -95.34B | -3.53% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zynex | 108.20M |
| China Medicine | 65.76M |
| PD-Rx Pharmaceuticals | 18.35M |
| Exlites Holdings International | 9.42M |
| Pharmagen | 4.41M |
| Gold Enterprise Group | 559.55K |
| Global Medical Products Holdings | 45.96K |
| DH Enchantment | -42.87K |